证券代码：301000 证券简称：肇民科技 公告编号：2025-045 上海肇民新材料科技股份有限公司 第二届董事会第二十四次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 一、董事会会议召开情况 上海肇民新材料科技股份有限公司（以下简称"公司"）第二届董事会第 二十四次会议通知于 2025 年 6 月 3 日通过电话、电子邮件等通讯方式发出，会 议通知列明了会议的召开时间、地点、内容和方式。本次会议于 2025 年 6 月 6 日在公司会议室以现场结合线上通讯方式召开，会议应出席董事 7 人，实际出 席董事 7 人（其中董事邵雄辉先生、颜爱民先生、刘浩先生、刘益灯先生、石 松佳子女士以通讯方式出席）。本次会议由董事长邵雄辉先生召集并主持，公 司高级管理人员列席了本次会议。本次会议的召开符合《中华人民共和国公司 法》等法律、法规和《公司章程》的有关规定，会议决议合法有效。 二、董事会会议审议情况 1、审议通过了《关于公司董事会换届选举暨选举第三届董事会非独立董事 的议案》 公司第二届董事会任期即将届满，应进行董事会换届选举。董事会提名委员 会进 ...

近5日机构合计调研302家公司，肇民科技、中微公司、华测检测等被多家机构扎堆调研。 证券时报·数据宝统计，近5个交易日（5月27日至6月3日）两市约302家公司被机构调研，调研机构类型 显示，证券公司共对272家公司进行调研，即90.07%的上市公司调研活动有证券公司参与；基金公司调 研232家，位列其后；阳光私募机构调研119家，排名第三。 机构调研榜单中，共有69家公司获20家以上机构扎堆调研。肇民科技最受关注，参与调研的机构达到 281家；中微公司被212家机构调研，榜单中排名第二；华测检测、拓荆科技等分别被187家、179家机构 调研。 机构调研次数来看，三友联众机构调研最为密集，共获机构4次调研。能辉科技、周大生等机构调研也 较为密集，均被机构调研3次。 数据宝统计，20家以上机构扎堆调研股中，近5日资金净流入的有24只，中科金财近5日净流入资金4.04 亿元，主力资金净流入最多；净流入资金较多的还有海大集团、北特科技等，净流入资金分别为2.46亿 元、1.27亿元。 市场表现上，机构扎堆调研股中，近5日上涨的有27只，涨幅居前的有华纳药厂、科兴制药、益方生物 等，涨幅为64.66%、53.29%、 ...

证券代码：301000 证券简称：肇民科技 公告编号：2025-043 上海肇民新材料科技股份有限公司 关于使用闲置募集资金和自有资金进行现金管理的进展公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 上海肇民新材料科技股份有限公司（以下简称"公司"）于2025年4月8日召开 了第二届董事会第二十二次会议、第二届监事会第二十一次会议，并于2025年5月 29日召开2024年年度股东会，审议通过了《关于使用闲置募集资金和自有资金进行 现金管理的议案》，同意公司使用暂时闲置募集资金不超过20,000万元（含本数） 和自有资金不超过40,000万元（含本数）进行现金管理，使用期限自股东会审议通 过之日起12个月内有效。在上述额度和期限内，资金可滚动使用。 公司保荐机构对上述事项均发表了明确同意的意见。具体内容详见公司于 2025年4月10日在巨潮资讯网（www.cninfo.com.cn）上披露的《上海肇民新材料科 技股份有限公司关于使用闲置募集资金和自有资金进行现金管理的公告》（公告 编号：2025-025）。 近日，公司对部分募集资金和自有资金理财产品进行 ...

Group 1: Investor Relations Activities - Multiple investor relations activities were conducted from April 10 to May 28, 2025, including phone meetings, specific object research, and roadshows [2][3][4][5][6][7][8][9][10][11][12][13][14][15] - Participants included various funds and securities companies such as Minsheng Securities, Huatai Securities, and Galaxy Fund [2][3][4][5][6][7][8][9][10][11][12][13][14][15] Group 2: Company Overview and Core Competencies - The company specializes in precision injection molding, focusing on the development of precision functional components for automotive and high-end home appliances [12][13] - Key materials used include engineering plastics such as PA, PPS, and PEEK, which are essential for high-performance applications [12][13] Group 3: Market Strategy and Future Plans - The company aims to expand its market share in the automotive sector, particularly in new energy vehicles, by developing precision components for thermal management modules and electric drive systems [13][14] - A new project for producing 800 million sets of new energy vehicle components and ultra-precision engineering plastic parts is underway, expected to be completed by 2026 [14][15] Group 4: Risk Management and Investor Advisory - The company emphasizes the importance of investor caution regarding the uncertainties in new product development and market introduction due to various influencing factors [13]

上海肇民新材料科技股份有限公司 2024 年年度股东会决议公告 证券代码：301000 证券简称：肇民科技 公告编号：2025-042 （五）本次股东会的召集和召开程序、出席会议人员的资格和召集人资格、 会议的表决程序和表决结果均符合相关法律法规及《公司章程》的规定。 二、会议出席情况 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或者重大遗漏。 重要提示 1、本次股东会没有出现否决议案的情形； 2、本次股东会没有涉及变更前次股东会决议。 一、会议召开情况 （一）股东会召开的时间：2025 年 5 月 29 日下午 15:00。 （二）网络投票时间：通过深圳证券交易所交易系统进行网络投票的具体时 间为：2025 年 5 月 29 日上午 9:15-9:25，9:30-11:30，下午 13:00-15:00；通过深 圳证券交易所互联网投票系统进行网络投票的具体时间为：2025 年 5 月 29 日上 午 9:15 时至 2025 年 5 月 29 日下午 15:00 时。 （三）股东会召开的地点：上海市金山区金山卫镇秦弯路 633 号上海肇民新 材料科技股份有限公司会议室 ...

北京德恒（杭州）律师事务所 关于 上海肇民新材料科技股份有限公司 杭州市上城区新业路 200 号华峰国际商务大厦 10-11 层 电话：0571-86508080 传真：0571-87357755 邮编：310016 北京德恒（杭州）律师事务所 关于上海肇民新材料科技股份有限公司 2024 年年度股东会的法律意见 北京德恒（杭州）律师事务所 关于 上海肇民新材料科技股份有限公司 2024 年年度股东会的 法律意见 2024 年年度股东会的 法律意见 德恒【杭】书（2025）第 05091 号 致：上海肇民新材料科技股份有限公司 北京德恒（杭州）律师事务所（以下简称"本所"）接受上海肇民新材料科技 股份有限公司（以下简称"公司"）的委托，指派本所律师对公司 2024 年年度股 东会（以下简称"本次会议"）的合法性进行见证并出具本法律意见。 本法律意见根据《中华人民共和国公司法》（以下简称"《公司法》"）、《中 华人民共和国证券法》（以下简称"《证券法》"）、《上市公司股东会规则》等 法律、法规、规范性文件以及《上海肇民新材料科技股份有限公司章程》（以下 简称"《公司章程》"）、《上海肇民新材料科技股份有限公司股 ...

Investment Rating - The report maintains a "Recommendation" rating for the humanoid robotics industry, indicating a positive outlook for the sector's fundamentals and expected performance exceeding the benchmark index [6]. Core Insights - The humanoid robotics sector is experiencing significant investment activity, with multiple companies securing substantial funding rounds, indicating strong market interest and growth potential [5][10][12]. - Partnerships between major tech firms, such as Huawei and UBTECH, are expected to enhance product development and application in industrial and household scenarios, further driving industry growth [2]. - The report highlights the emergence of autonomous logistics as a rapidly deployable application for embodied intelligence, with the potential to unlock a market exceeding 100 billion [12]. Summary by Sections Investment Activities - Skild AI is set to complete a $500 million financing round at a valuation of $4.2 billion, led by SoftBank and other prominent investors, aimed at expanding its robotics capabilities [1]. - Qianjue Robotics announced the completion of a multi-million angel round financing to accelerate technology development and product iteration [3]. - Ziyuan Robotics completed a multi-million A round financing, with funds directed towards the development of its end-to-end embodied intelligence model [5]. Strategic Partnerships - Huawei and UBTECH signed a comprehensive cooperation agreement to innovate in humanoid robotics, leveraging Huawei's technological capabilities and UBTECH's expertise [2]. - Yujian Technology and Tencent Cloud have deepened their strategic cooperation to accelerate innovation in embodied intelligence technology across various applications [4]. Market Performance - The humanoid robotics industry has shown strong performance metrics, with a notable increase in stock prices for key players, indicating robust investor confidence [17]. - The report outlines a significant increase in the number of financing events in the humanoid robotics sector, reflecting a growing interest from venture capital and institutional investors [18][20].

Summary of Key Points Core Viewpoint The announcement details the results of the second vesting period of the 2023 Restricted Stock Incentive Plan for Shanghai Zhaomin New Materials Technology Co., Ltd, indicating that the vesting conditions have been met and shares will be listed for trading. Group 1: Incentive Plan Overview - The company held meetings to approve the 2023 Restricted Stock Incentive Plan, which was initially granted on March 20, 2023, with a grant price of 15.25 yuan per share [1][14]. - The total number of restricted shares granted was adjusted from 330,000 to 594,000 shares, with the final grant price set at 5.21 yuan per share [14][25]. - The plan includes 35 middle management and core technical personnel as recipients, with a total of 41,000 shares allocated [1][2]. Group 2: Vesting Conditions and Results - The second vesting period for the restricted shares is from March 20, 2025, to March 19, 2026, and the number of shares eligible for vesting is 235,872 shares for 34 recipients [15][22]. - The vesting conditions were confirmed to have been met, with no adverse financial reports or regulatory issues affecting the company [16][18]. - The shares will be listed for trading on May 16, 2025 [24]. Group 3: Performance Assessment - The performance assessment for the incentive plan spans three fiscal years (2023-2025), with specific net profit growth targets set for each year [20][21]. - The net profit for 2022 was used as a baseline for calculating growth targets, with a target growth rate of 54.04% for the first vesting period [21]. - The performance metrics include both company-level and individual-level assessments, with a detailed scoring system for personal performance [10][20]. Group 4: Financial Impact - The total share capital will increase from 242,159,450 shares to 242,395,322 shares following the vesting, which may dilute earnings per share [26]. - The funds raised from the share issuance will be used to supplement the company's working capital [24]. - The independent financial advisor confirmed that the vesting conditions and adjustments comply with relevant laws and regulations [27].

证券代码：301000 证券简称：肇民科技 公告编号：2025-041 上海肇民新材料科技股份有限公司 关于2023年限制性股票激励计划首次授予部分 第二个归属期归属结果暨股份上市的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 重要内容提示： 1、本次归属股票上市流通日：2025 年 5 月 16 日 2、本次归属股票数量：235,872 股（调整后），占归属前上市公司总股本的 0.1%。 3、本次归属股票人数：34 人 4、本次归属股票上市流通安排：本次归属的限制性股票无其他限售安排， 股票上市后即可流通 上海肇民新材料科技股份有限公司（以下简称"公司"）于 2025 年 4 月 8 日召开第二届董事会第二十二次会议和第二届监事会第二十一次会议，审议通过 了《关于 2023 年限制性股票激励计划首次授予部分第二个归属期归属条件成就 的议案》。近日，公司办理了 2023 年限制性股票激励计划（以下简称"本次激 励计划"或"本激励计划"）首次授予的限制性股票第二个归属期股份登记工作， 现将相关事项说明如下： 一、本次激励计划实施情况概要 （一）本次激励计 ...

Investment Rating - The report maintains an "Accumulate" rating for the company [1] Core Insights - In Q1 2025, the company achieved revenue of 190 million yuan, representing a year-on-year increase of 20.20%. The net profit attributable to shareholders was 36 million yuan, up 2.84% year-on-year, while the net profit after deducting non-recurring gains and losses was 35 million yuan, reflecting a 15.26% increase year-on-year [5][8] - The company is focusing on expanding its market share in precision injection parts and molds, particularly in the automotive and high-end home appliance sectors, while accelerating the development of its robotics products [8][10] - The company is expected to see continued growth driven by both its main business and emerging sectors, with projected revenues of 959 million yuan, 1.144 billion yuan, and 1.321 billion yuan for 2025, 2026, and 2027 respectively, representing year-on-year growth rates of 27%, 19%, and 15% [10][11] Financial Performance - The company's gross margin for Q1 2025 was 34.63%, a decrease of 0.42 percentage points year-on-year, and the net profit margin was 19.44%, down 3 percentage points year-on-year, primarily due to rising expense ratios and reduced government subsidies [8][10] - The company has developed several new precision components for humanoid robots, leveraging its experience in engineering plastics and precision manufacturing [8][10] Future Projections - The earnings per share (EPS) are projected to be 0.78 yuan, 0.95 yuan, and 1.10 yuan for 2025, 2026, and 2027 respectively, with net profit attributable to shareholders expected to reach 190 million yuan, 230 million yuan, and 267 million yuan during the same period [10][11]